nq093014ngf.htm
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

FORM N-Q
QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED
MANAGEMENT INVESTMENT COMPANY
_______________________________
 
Investment Company Act file number:  811-05983
 
The New Germany Fund, Inc.
(Exact name of registrant as specified in charter)

345 Park Avenue
New York, NY 10154
(Address of principal executive offices)  (Zip code)
 

Paul Schubert
60 Wall Street
New York, NY 10005
(Name and address of agent for service)
 
Registrant's telephone number, including area code:  (212) 250-3220
 
Date of fiscal year end:  12/31
 
Date of reporting period:  9/30/2014

ITEM 1.
SCHEDULE OF INVESTMENTS


   
THE NEW GERMANY FUND, INC.
SCHEDULE OF INVESTMENTS — SEPTEMBER 30, 2014 (unaudited)
 
 
Shares
 
Description
Value(a)
 
INVESTMENTS IN GERMANY – 80.8%
     
   
COMMON STOCKS – 78.0%
 
   
AEROSPACE & DEFENSE – 1.2%
 
 
39,647
   
MTU Aero Engines
$
3,384,209
   
   
AUTO COMPONENTS – 1.4%
 
 
50,112
   
Leoni
 
2,734,807
   
 
99,805
   
SAF-Holland
 
1,230,874
   
   
3,965,681
   
   
CHEMICALS – 8.8%
 
 
181,961
   
Evonik Industries
 
6,304,674
   
 
230,712
   
Symrise
 
12,284,966
   
 
48,174
   
Wacker Chemie
 
5,828,056
   
   
24,417,696
   
   
COMMERCIAL SERVICES &
SUPPLIES – 1.1%
 
 
47,098
   
Bilfinger Berger
 
2,986,021
   
   
CONSTRUCTION &
ENGINEERING – 0.5%
 
 
20,526
   
Hochtief
 
1,412,800
   
   
DIVERSIFIED
TELECOMMUNICATION
SERVICES – 0.8%
 
 
432,154
   
Telefonica Deutschland Holding
 
2,259,119
   
   
ELECTRICAL EQUIPMENT – 4.3%
 
 
211,339
   
Nordex*
 
3,897,458
   
 
217,025
   
OSRAM Licht Group*
 
8,082,735
   
   
11,980,193
   
   
ELECTRONIC EQUIPMENT,
INSTRUMENTS &
COMPONENTS – 1.3%
 
 
15,546
   
Isra Vision
 
952,052
   
 
179,637
   
Jenoptik
 
2,019,900
   
 
31,254
   
LPKF Laser & Electronics†
 
549,147
   
   
3,521,099
   
   
FOOD & STAPLES
RETAILING – 2.4%
 
 
204,478
   
Metro*
 
6,733,709
   
   
HEALTH CARE EQUIPMENT &
SERVICES – 0.8%
 
 
43,626
   
STRATEC Biomedical†
 
2,263,506
   
 
Shares
 
Description
Value(a)
 
   
HEALTH CARE PROVIDERS &
SERVICES – 3.2%
 
 
297,848
   
Rhoen Klinikum†
$
9,033,746
   
   
HEALTH CARE
TECHNOLOGY – 0.3%
 
 
32,437
   
CompuGroup Medical
 
776,567
   
   
HOTELS, RESTAURANTS &
LEISURE – 1.4%
 
 
268,025
   
TUI
 
4,008,765
   
   
INDUSTRIAL
CONGLOMERATES – 0.6%
 
 
34,080
   
Rheinmetall
 
1,639,550
   
   
INSURANCE – 3.4%
 
 
54,968
   
Hannover Rueck
 
4,443,506
   
 
151,053
   
Talanx
 
5,024,904
   
   
9,468,410
   
   
INTERNET SOFTWARE &
SERVICES – 4.1%
 
 
158,341
   
United Internet
 
6,736,883
   
 
45,357
   
XING
 
4,827,481
   
   
11,564,364
   
   
IT SERVICES – 1.8%
 
 
20,362
   
Bechtle
 
1,557,836
   
 
90,179
   
Wirecard
 
3,331,238
   
   
4,889,074
   
   
LIFE SCIENCES TOOLS &
SERVICES – 3.0%
 
 
128,970
   
Evotec*†
 
504,673
   
 
67,502
   
Gerresheimer
 
4,382,772
   
 
35,291
   
MorphoSys*
 
3,462,018
   
   
8,349,463
   
   
MACHINERY – 8.4%
 
 
85,934
   
DMG MORI SEIKI
 
2,428,971
   
 
34,975
   
Duerr
 
2,553,942
   
 
184,953
   
GEA Group
 
8,067,645
   
 
55,597
   
Krones
 
4,834,133
   
 
30,408
   
NORMA Group
 
1,271,681
   
 
4,776
   
Rational
 
1,420,219
   
 
88,095
   
Stabilus*
 
2,717,089
   
   
23,293,680
   
 

 
 
7
 
 
 

 

THE NEW GERMANY FUND, INC.
 
SCHEDULE OF INVESTMENTS — SEPTEMBER 30, 2014 (unaudited) (continued)
 
Shares
 
Description
Value(a)
 
INVESTMENTS IN GERMANY – 80.8% (continued)
     
   
MEDIA – 7.2%
 
 
59,721
   
Axel Springer
$
3,287,109
   
 
269,322
   
ProSiebenSat.1 Media
 
10,729,300
   
 
458,177
   
Sky Deutschland*
 
3,892,996
   
 
95,204
   
Stroeer Media
 
2,097,736
   
   
20,007,141
   
   
METALS & MINING – 1.3%
 
 
42,431
   
Aurubis
 
2,098,100
   
 
46,608
   
Salzgitter
 
1,606,951
   
   
3,705,051
   
   
PHARMACEUTICALS – 0.7%
 
 
51,120
   
Stada Arzneimittel
 
2,033,623
   
   
PROFESSIONAL
SERVICES – 0.5%
 
 
21,818
   
Amadeus Fire
 
1,525,145
   
   
REAL ESTATE
MANAGEMENT &
DEVELOPMENT – 8.1%
 
 
395,131
   
Deutsche Annington Immobilien
 
11,465,456
   
 
160,072
   
LEG Immobilien
 
11,090,484
   
   
22,555,940
   
   
SEMICONDUCTORS &
SEMICONDUCTOR
EQUIPMENT – 2.2%
 
 
98,923
   
Dialog Semiconductor*
 
2,778,625
   
 
531,832
   
Kontron*
 
3,328,845
   
   
6,107,470
   
   
SPECIALTY RETAIL – 0.8%
 
 
35,316
   
Fielmann
 
2,167,022
   
   
TECHNOLOGY HARDWARE,
STORAGE &
PERIPHERALS – 0.3%
 
 
15,370
   
Wincor Nixdorf
 
787,176
   
   
TEXTILES, APPAREL &
LUXURY GOODS – 1.9%
 
 
68,319
   
Gerry Weber International
 
2,697,119
   
 
20,840
   
Hugo Boss
 
2,604,100
   
   
5,301,219
   
   
THRIFTS & MORTGAGE
FINANCE – 1.9%
 
 
120,254
   
Aareal Bank
 
5,228,014
   
 
Shares
 
Description
Value(a)
 
   
TRADING COMPANIES &
DISTRIBUTORS – 2.5%
 
 
112,098
   
Brenntag
$
5,507,560
   
 
114,899
   
Kloeckner*
 
1,580,679
   
   
7,088,239
   
   
WIRELESS
TELECOMMUNICATION
SERVICES – 1.8%
 
 
195,367
   
Freenet
 
5,083,046
   
       
Total Common Stocks
(cost $181,873,127)
 
217,536,738
   
   
PREFERRED STOCKS – 2.8%
 
   
CONSTRUCTION
MATERIALS – 0.9%
 
 
15,056
   
Sto
(cost $2,540,671)
 
2,695,790
   
   
HEALTH CARE
EQUIPMENT &
SUPPLIES – 1.0%
 
 
30,665
   
Draegerwerk†
(cost $3,559,932)
 
2,714,321
   
   
SPECIALTY RETAIL – 0.9%
 
 
31,614
   
Hornbach Holding
(cost $3,239,684)
 
2,498,929
   
       
Total Preferred Stocks
(cost $9,340,287)
 
7,909,040
   
       
Total Investments in Germany
(cost $191,213,414)
 
225,445,778
   
INVESTMENTS IN NETHERLANDS – 13.2%
     
   
AEROSPACE &
DEFENSE – 10.4%
 
 
460,000
   
Airbus Group NV
 
28,937,549
   
   
LIFE SCIENCES TOOLS &
SERVICES – 2.8%
 
 
347,319
   
QIAGEN*
 
7,907,231
   
       
Total Investments in Netherlands
(cost $19,110,728)
 
36,844,780
   
 

 
 
8
 
 
 

 

THE NEW GERMANY FUND, INC.
 
SCHEDULE OF INVESTMENTS — SEPTEMBER 30, 2014 (unaudited) (continued)
 
Shares
 
Description
Value(a)
 
INVESTMENTS IN LUXEMBOURG – 2.7%
     
   
MEDIA – 2.7%
 
 
87,354
   
RTL Group
$
7,488,396
   
       
Total Investments in Luxembourg
(cost $6,352,695)
 
7,488,396
   
INVESTMENTS IN SWITZERLAND – 1.3%
     
   
CLOSED-END FUNDS – 1.3%
 
   
HEALTH CARE – 1.3%
 
 
17,529
   
BB Biotech*
 
3,413,042
   
       
Total Investments in Switzerland
(cost $3,413,542)
 
3,413,042
   
       
Total Investments in Common
and Preferred Stocks – 98.0%
(cost $220,090,379)
 
273,191,996
   
SECURITIES LENDING COLLATERAL – 3.5%
     
 
9,870,186
   
Daily Assets Fund
Institutional, 0.08%
(cost $9,870,186)(b)(c)
 
9,870,186
 
 
 
 
 
Shares
 
Description
Value(a)
 
CASH EQUIVALENTS – 2.2%
 
 
6,253,195
   
Central Cash Management
Fund, 0.05%
(cost $6,253,195)(c)
$
6,253,195
   
   
Total Investments – 103.7%
(cost $236,213,760)**
 
289,315,377
   
   
Other Assets and Liabilities,
Net – (3.7%)
 
(10,280,966
)
 
   
NET ASSETS – 100.0%
$
279,034,411
   
 
For information on the Fund's policies regarding the valuation of investments and other significant accounting policies, please refer to the Fund's most recent semi-annual or annual financial statements.
*  Non-income producing security.
**  The cost for federal income tax purposes was $237,002,249. At September 30, 2014, net unrealized appreciation for all securities based on tax cost was $52,313,128. This consisted of aggregate gross unrealized appreciation for all securities in which there was an excess of value over tax cost of $69,919,924 and aggregate gross unrealized depreciation for all securities in which there was an excess of tax cost over value of $17,606,796.
†  All or a portion of these securities were on loan. The value of all securities loaned at September 30, 2014 amounted to $9,515,871, which is 3.4% of net assets.
(a)  Value stated in U.S. dollars.
(b)  Represents collateral held in connection with securities lending. Income earned by the Fund is net of borrower rebates.
(c)  Affiliated fund managed by Deutsche Investment Management Americas Inc. The rate shown is the annualized seven-day yield at period end.
For purposes of its industry concentration policy, the Fund classifies issuers of portfolio securities at the industry sub-group level. Certain of the categories in the above Schedule of Investments consist of multiple industry sub-groups or industries.
 

 
 
9
 
 
 

 

THE NEW GERMANY FUND, INC.
 
SCHEDULE OF INVESTMENTS — SEPTEMBER 30, 2014 (unaudited) (continued)
 
Fair Value Measurements
Various inputs are used in determining the value of the Fund's investments. These inputs are summarized in three broad levels. Level 1 includes quoted prices in active markets for identical securities. Level 2 includes other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds and credit risk). Level 3 includes significant unobservable inputs (including the Fund's own assumptions in determining the fair value of investments). The level assigned to the securities valuations may not be an indication of the risk associated with investing in those securities.
 
The following is a summary of the inputs used as of September 30, 2014 in valuing the Fund's investments.
Assets
Level 1
 
Level 2
 
Level 3
 
Total
 
Common Stocks and/or Other Equity Investments(1)
 
Germany
$
225,445,778
   
$
   
$
   
$
225,445,778
   
Netherlands
 
36,844,780
     
     
     
36,844,780
   
Luxembourg
 
7,488,396
     
     
     
7,488,396
   
Switzerland
 
3,413,042
     
     
     
3,413,042
   
Short-Term Instruments(1)
 
16,123,381
     
     
     
16,123,381
   
Total
$
289,315,377
   
$
   
$
   
$
289,315,377
   
 
There have been no transfers between fair value measurement levels during the period ended September 30, 2014.
 
 
(1) See Schedule of Investments for additional detailed categorizations.
 

 
 
10
 
 
 

 





ITEM 2.
CONTROLS AND PROCEDURES
   
 
(a)   The Chief Executive and Financial Officers concluded that the Registrant’s Disclosure Controls and Procedures are effective based on the evaluation of the Disclosure Controls and Procedures as of a date within 90 days of the filing date of this report.
   
 
(b)   There have been no changes in the registrant’s internal control over financial reporting that occurred during the registrant’s last fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal controls over financial reporting.
   
ITEM 3.
EXHIBITS
   
 
Certification pursuant to Rule 30a-2(a) under the Investment Company Act of 1940 (17 CFR 270.30a-2(a)) is filed and attached hereto as Exhibit 99.CERT.


 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Registrant:
The New Germany Fund, Inc.
   
By:
/s/Brian E. Binder
Brian E. Binder
President
   
Date:
November 21, 2014


Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

By:
/s/Brian E. Binder
Brian E. Binder
President
   
Date:
November 21, 2014
   
   
   
By:
/s/Paul Schubert
Paul Schubert
Chief Financial Officer and Treasurer
   
Date:
November 21, 2014